@article{12940eaa907740eda49ff72ef549e214,
title = "Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of renal mass biopsy in the management of kidney cancer",
author = "Lavall{\'e}e, {Luke T.} and Kristen McAlpine and Anil Kapoor and Fr{\'e}d{\'e}ric Pouliot and Ross Mason and Violette, {Philippe D.} and Bansal, {Rahul K.} and Richard, {Patrick O.} and Karakiewicz, {Pierre I.} and Bimal Bhindi and Ranjena Maloni and Stephen Pautler and Lattouf, {Jean Baptiste} and Wassim Kassouf and Simon Tanguay and Alan So and Rendon, {Ricardo A.} and Breau, {Rodney H.}",
note = "Funding Information: Competing interests: Dr. Lavall{\'e}e has been an advisory board member for Ferring and Sanofi; and received a grant from Sanofi. Dr. Kapoor has attended advisory boards for and participated in clinical trials supported by Amgen, Astellas, Janssen, GSK, Novartis, Pfizer, and Sanofi. Dr. Pouliot has been an advisory board member for Amgen, Astellas, and Pfizer; has been a speaker for Sanofi; and has received payment/grants/honoraria from Amgen, Astellas, AstraZeneca, Janssen, Pfizer, and Sanofi. Dr. Violette has been a speaker for Janssen and Sanofi (with no honoraria). Dr. Richard has been an advisory board member for BMS and Sanofi; has been a speaker for Abbvie, Amgen, Astellas, Ferring, and Janssen; and has participated in clinical trials for Calithera and Lidds Pharma. Dr. Karakiewicz has been an advisory board member for Pfizer; has received payment for advisory board presentations from Abbvie, Astellas, Ferring, Janssen, and Pfizer; and has received a research grant from Pfizer. Dr. Lattouf has been an advisory board member for and received honoraria from Abbvie, AstraZeneca, Bayer, Novartis, Pfizer, and Takeda. Dr. Kassouf has received grants/ honoraria from Astellas, AstraZeneca, Janssen, Merck, and Roche. Dr. Tanguay has been an advisory board member for Pfizer; and received a travel grant from Sanofi. Dr. So has been a speaker for Amgen, Astellas, and Janssen. Dr. Rendon has been an advisory board member and speaker for, and received honoraria from Abbvie, Amgen, Astellas, Astra Zeneca, Bayer, Ferring, Jansen, and Sanofi. The remaining authors report no competing personal or financial interests related to this work.",
year = "2019",
doi = "10.5489/cuaj.6346",
language = "English",
volume = "13",
pages = "377--383",
journal = "Journal of the Canadian Urological Association",
issn = "1911-6470",
publisher = "Canadian Medical Association",
number = "12",
}
